Home / PNMA8C Knockout Cell Lines

PNMA8C Knockout Cell Lines

Gene: PNMA8C

Official Full Name: PNMA family member 8Cprovided by HGNC

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO15007 PNMA8C Knockout cell line (HeLa) Human PNMA8C 1:3~1:6 Negative Online Inquiry
KO15008 PNMA8C Knockout cell line (HCT 116) Human PNMA8C 1:2~1:4 Negative Online Inquiry
KO15009 PNMA8C Knockout cell line (A549) Human PNMA8C 1:3~1:4 Negative Online Inquiry

Background

PNMA8C Gene Knockout Cell Lines are genetically modified cell lines that have had the PNMA8C gene (also known as the paraneoplastic Ma antigens) disrupted to study its functional role and implications in various biological processes. The knockout technique involves precise gene editing technologies, such as CRISPR-Cas9, which enables researchers to create a loss-of-function model that aids in elucidating the gene's contributions to cellular mechanisms and disease states.

These cell lines provide critical insights into neurological disorders and potential cancer mechanisms, as PNMA8C is implicated in paraneoplastic syndromes. By knocking out the PNMA8C gene, researchers can investigate downstream effects on cell signaling, proliferation, and differentiation. The mechanisms revealed in these studies are vital for developing targeted therapies and enhancing our understanding of tumorigenesis associated with neurodegenerative diseases.

What distinguishes PNMA8C Gene Knockout Cell Lines is their specificity and reliability when compared to alternative models. Unlike conventional models, which may involve artificial overexpression or random integrations, these knockout lines provide a clean genetic background that accurately represents the loss of PNMA8C function. This specificity minimizes variability in results, ensuring that findings are directly attributable to changes in the PNMA8C gene.

The value of these cell lines extends beyond pure research; they serve as a platform for drug discovery and testing, enabling clinicians and pharmaceutical companies to evaluate potential therapeutics targeting associated pathways. Additionally, the use of PNMA8C knockout cells in preclinical studies can significantly enhance the translational potential of research findings to clinical applications.

Our company is committed to advancing the field of genetics and cellular biology through innovative products tailored for researchers and clinicians alike. With expertise in genetic engineering and a focus on high-quality solutions, we provide essential tools that empower scientific discovery and therapeutic advancements.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.